Lotus Pharmaceutical Co., Ltd. (1795.TW)

305,00 -5,50 (-1,77%) Al cierre: 01:30PM CST

Lotus Pharmaceutical Co., Ltd.

No. 277 Song Ren Road
17th Floor Xin Yi District
Taipei 110
Taiwan
886 2 2700 5908
https://www.lotuspharm.com.tw

Sector(es): Healthcare
Sector: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Petar Antonov Vazharov	CEO & Director	34,72M	N/A	N/A
Mr. Zenon Zdunek	Vice President of Supply Chain & Operations	12,83M	N/A	N/A
Ms. Eeling Chan	Chief Financial Officer	5,19M	N/A	N/A
Ms. Gwen Hsieh	Chief Information Officer	N/A	N/A	N/A
Ms. Yu-Ying Yang	Associate Director of Co-Operate Communication	N/A	N/A	N/A
Boon Chong Tan	Deputy General Manager	N/A	N/A	N/A
Mr. Edin Buljubasic	Vice President	N/A	N/A	N/A
Yingming Yue	Vice President	N/A	N/A	N/A
Valerie Lau	Chief Commercial Officer-APAC	N/A	N/A	N/A
Mr. Manish Chawla	Vice President of Research and Development	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2021 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en TWD.

Descripción

Lotus Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, cardiology, nephrology, women's health, anti-obesity, and central nervous system diseases. The company also provides over-the-counter products. In addition, it engages in retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical products; marketing activities; market planning and business information services; and consultancy services on health management, health technology, and trading information services. Further, the company offers management consultancy services; pharmaceutical regulatory affairs project management, and data collection and agency services; healthcare consultancy services and operates as a contract research organization. The company has strategic partnership with NRX Pharmaceuticals. Lotus Pharmaceutical Co., Ltd. was incorporated in 1966 and is headquartered in Taipei City, Taiwan.

Gobierno corporativo

El ISS Governance QualityScore de Lotus Pharmaceutical Co., Ltd., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.